Clinical features and risk factors associated with severe COVID-19 patients in ChinaNing Jiang, Zhancheng Gao, Yan‐Nan Liu et al.|Chinese Medical Journal|2021Cited by 26
Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trialHongzhou Lu, Nanshan Zhong, Yangqing Zhan et al.|EClinicalMedicine|2024Cited by 23